Erratum: Effects of the sodium-glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease

Claire C J Dekkers, David C Wheeler, C David Sjöström, Bergur V Stefansson, Valerie Cain, Hiddo J L Heerspink

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
113 Downloads (Pure)
Original languageEnglish
Pages (from-to)1280
Number of pages1
JournalNephrology, Dialysis, Transplantation
Volume33
Issue number7
DOIs
Publication statusPublished - 1-Jul-2018

Cite this